Tan, Michael Jay M.
HRN: 22-77-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/02/2023
04/04/2023
IV
875mg
Q6
Fracture Closed Complete Proximal 3rd Femur Left
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes